RAFAEL HOLDINGS, INC. Comprehensive Income
RAFAEL HOLDINGS, INC. (RFL) reported Comprehensive Income of -$3.94 million for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-04-30 was -$3.94M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-01-31 was -$6.37M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-10-31 was -$9.78M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-07-31 was -$11.89M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$30.17M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$34.00M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$2.21M.
- RAFAEL HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$124.70M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-04-30 | -$3.94M 10-Q · filed 2026-06-11 | -$10.30M derived: sum of 2 quarters · filed 2026-06-11 | -$20.08M 10-Q · filed 2026-06-11 | -$31.97M derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2026-01-31 | -$6.37M 10-Q · filed 2026-03-16 | -$16.14M 10-Q · filed 2026-03-16 | -$28.04M derived: sum of 3 quarters · filed 2026-03-16 | -$32.73M derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-10-31 | -$9.78M 10-Q · filed 2025-12-12 | -$21.67M derived: sum of 2 quarters · filed 2025-12-12 | -$26.36M derived: sum of 3 quarters · filed 2026-06-11 | -$30.97M derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-07-31 | -$11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$16.58M derived: sum of 2 quarters · filed 2026-06-11 | -$21.19M derived: sum of 3 quarters · filed 2026-06-11 | -$30.17M 10-K · filed 2025-10-29 | ||
| 2025-04-30 | -$4.69M 10-Q · filed 2026-06-11 | -$9.30M derived: sum of 2 quarters · filed 2026-06-11 | -$18.28M 10-Q · filed 2026-06-11 | -$22.60M derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-01-31 | -$4.61M 10-Q · filed 2026-03-16 | -$13.59M 10-Q · filed 2026-03-16 | -$17.91M derived: sum of 3 quarters · filed 2026-03-16 | -$50.23M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-10-31 | -$8.98M 10-Q · filed 2025-12-12 | -$13.30M derived: sum of 2 quarters · filed 2025-12-12 | -$45.62M derived: sum of 3 quarters · filed 2025-12-12 | -$39.47M derived: sum of 4 quarters · filed 2025-12-12 | ||
| 2024-07-31 | -$4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$36.64M derived: sum of 2 quarters · filed 2025-10-29 | -$30.49M derived: sum of 3 quarters · filed 2025-10-29 | -$34.00M 10-K · filed 2025-10-29 | ||
| 2024-04-30 | -$32.32M 10-Q · filed 2025-06-11 | -$26.16M derived: sum of 2 quarters · filed 2025-06-11 | -$29.67M 10-Q · filed 2025-06-11 | -$28.41M derived: sum of 4 quarters · filed 2025-06-11 | ||
| 2024-01-31 | $6.15M 10-Q · filed 2025-03-14 | $2.64M 10-Q · filed 2025-03-14 | $3.90M derived: sum of 3 quarters · filed 2025-03-14 | $1.75M derived: sum of 4 quarters · filed 2025-03-14 | ||
| 2023-10-31 | -$3.51M 10-Q · filed 2024-12-11 | -$2.25M derived: sum of 2 quarters · filed 2024-12-20 | -$4.41M derived: sum of 3 quarters · filed 2024-12-20 | -$7.41M derived: sum of 4 quarters · filed 2024-12-20 | ||
| 2023-07-31 | $1.26M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$895.00K derived: sum of 2 quarters · filed 2024-12-20 | -$3.90M derived: sum of 3 quarters · filed 2024-12-20 | -$2.21M 10-K/A · filed 2024-12-20 | ||
| 2023-04-30 | -$2.15M 10-Q · filed 2024-06-14 | -$5.16M derived: sum of 2 quarters · filed 2024-06-14 | -$3.47M 10-Q · filed 2024-06-14 | -$8.27M derived: sum of 4 quarters · filed 2024-06-14 | ||
| 2023-01-31 | -$3.00M 10-Q · filed 2024-03-14 | -$1.32M 10-Q · filed 2024-03-14 | -$6.12M derived: sum of 3 quarters · filed 2024-03-14 | -$11.88M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2022-10-31 | $1.69M 10-Q · filed 2023-12-14 | -$3.11M derived: sum of 2 quarters · filed 2023-12-14 | -$8.87M derived: sum of 3 quarters · filed 2023-12-14 | -$10.96M derived: sum of 4 quarters · filed 2023-12-14 | ||
| 2022-07-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$10.56M derived: sum of 2 quarters · filed 2023-10-30 | -$12.65M derived: sum of 3 quarters · filed 2023-10-30 | -$124.70M 10-K · filed 2023-10-30 | ||
| 2022-04-30 | -$5.76M 10-Q · filed 2023-06-13 | -$7.85M derived: sum of 2 quarters · filed 2023-06-13 | -$119.90M 10-Q · filed 2023-06-13 | -$149.81M derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2022-01-31 | -$2.09M 10-Q · filed 2023-03-14 | -$114.14M 10-Q · filed 2023-03-14 | -$144.04M derived: sum of 3 quarters · filed 2023-03-14 | -$146.66M derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-10-31 | -$129.44M 10-Q · filed 2022-12-13 | -$141.96M derived: sum of 2 quarters · filed 2022-12-13 | -$144.57M derived: sum of 3 quarters · filed 2022-12-13 | -$152.71M derived: sum of 4 quarters · filed 2022-12-13 | ||
| 2021-07-31 | -$12.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$15.13M derived: sum of 2 quarters · filed 2022-10-31 | -$23.27M derived: sum of 3 quarters · filed 2022-10-31 | -$24.79M 10-K · filed 2022-10-31 | ||
| 2021-04-30 | -$2.62M 10-Q · filed 2022-06-14 | -$10.76M derived: sum of 2 quarters · filed 2022-06-14 | -$12.28M 10-Q · filed 2022-06-14 | -$17.79M derived: sum of 4 quarters · filed 2022-06-14 | ||
| 2021-01-31 | -$8.14M 10-Q · filed 2022-03-17 | -$8.21M 10-Q · filed 2021-03-17 | -$9.60M 10-Q · filed 2022-03-17 | -$9.66M 10-Q · filed 2021-03-17 | -$15.18M derived: sum of 3 quarters · filed 2022-03-17 | -$17.42M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-10-31 | -$1.49M 10-Q/A · filed 2022-02-28 | -$7.04M derived: sum of 2 quarters · filed 2022-02-28 | -$9.28M derived: sum of 3 quarters · filed 2022-02-28 | -$10.63M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-07-31 | -$5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$7.79M derived: sum of 2 quarters · filed 2021-10-18 | -$9.14M derived: sum of 3 quarters · filed 2021-10-18 | -$10.78M 10-K · filed 2021-10-18 | ||
| 2020-04-30 | -$2.24M 10-Q · filed 2021-06-14 | -$3.59M derived: sum of 2 quarters · filed 2021-06-14 | -$5.24M 10-Q · filed 2021-06-14 | -$7.12M derived: sum of 4 quarters · filed 2021-06-14 | ||
| 2020-01-31 | -$1.34M 10-Q · filed 2021-03-17 | -$2.99M 10-Q · filed 2021-03-17 | -$4.88M derived: sum of 3 quarters · filed 2021-03-17 | -$6.06M derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2019-10-31 | -$1.65M 10-Q · filed 2020-12-15 | -$3.53M derived: sum of 2 quarters · filed 2020-12-15 | -$4.71M derived: sum of 3 quarters · filed 2020-12-15 | -$5.35M derived: sum of 4 quarters · filed 2020-12-15 | ||
| 2019-07-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | -$3.07M derived: sum of 2 quarters · filed 2020-10-29 | -$3.70M derived: sum of 3 quarters · filed 2020-10-29 | -$4.45M 10-K · filed 2020-10-29 | ||
| 2019-04-30 | -$1.18M 10-Q · filed 2019-06-05 | -$1.82M derived: sum of 2 quarters · filed 2020-03-05 | -$2.57M 10-Q · filed 2019-06-05 | -$1.87M derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2019-01-31 | -$636.00K 10-Q · filed 2020-03-05 | -$1.39M 10-Q · filed 2020-03-05 | -$689.00K derived: sum of 3 quarters · filed 2020-03-05 | -$1.72M derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2018-10-31 | -$596.00K 10-Q · filed 2019-12-09 | -$394.00K 10-Q · filed 2018-12-10 | -$53.00K derived: sum of 2 quarters · filed 2019-12-09 | -$1.08M derived: sum of 3 quarters · filed 2019-12-09 | -$1.75M derived: sum of 4 quarters · filed 2019-12-09 | |
| 2018-07-31 | $543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | -$483.00K derived: sum of 2 quarters · filed 2019-10-04 | -$1.16M derived: sum of 3 quarters · filed 2019-10-04 | -$10.46M 10-K · filed 2019-10-04 | ||
| 2018-04-30 | -$1.03M 10-Q · filed 2019-06-05 | -$1.70M derived: sum of 2 quarters · filed 2019-06-05 | -$11.00M 10-Q · filed 2019-06-05 | -$9.00M derived: sum of 4 quarters · filed 2019-06-05 | ||
| 2018-01-31 | -$673.00K 10-Q · filed 2019-03-12 | -$9.99M 10-Q · filed 2019-03-12 | -$7.98M derived: sum of 3 quarters · filed 2019-03-12 | -$8.02M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-10-31 | -$9.32M 10-Q · filed 2018-12-10 | -$7.30M derived: sum of 2 quarters · filed 2018-12-10 | -$7.35M derived: sum of 3 quarters · filed 2018-12-10 | -$7.17M derived: sum of 4 quarters · filed 2018-12-10 | ||
| 2017-07-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $1.97M derived: sum of 2 quarters · filed 2018-10-15 | $2.14M derived: sum of 3 quarters · filed 2018-10-15 | $2.27M 10-K · filed 2018-10-15 | ||
| 2017-04-30 | -$43.00K 10-Q · filed 2018-06-11 | $131.00K derived: sum of 2 quarters · filed 2018-06-11 | $252.00K 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | $174.00K 10-Q · filed 2018-03-12 | $302.00K 10-Q · filed 2018-03-12 | ||||
| 2016-07-31 | $703.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |